We examined the cerebral circulatory effects of intra-carotid infu sion of histamine or its receptor agonists in anesthetized rats. Cerebral blood flow was measured by two methods: an intracarotid I:l3Xe clearance technique and tissue sampling after systemic administration of the diffusible tracer, 
The biogenic amine, histamine, is present in nearly all mammalian tissues, and is regarded as one of the most potent of natural vasoactive substances in peripheral organs (Owen, 1977; Rossi, 1979) . Histamine is present in the brain. It has been de tected in perivascular mast cells (Ibrahim, 1974; Edvinsson et al. , 1977) , within cerebrovascular smooth muscle (EI-Ackad and Brody, 1974) , and is proposed to have a neurotransmitter role in the central nervous system (Green et al. , 1978; Schwartz et aI. , 1980) . Several normal and patho logical conditions, therefore, could involve locally or systemically increased levels of histamine that may influence brain vascular function.
The effect that histamine has on cerebral blood flow is controversial. (1) It has been reported that histamine is a potent dilating agent in the brain cir culation (Sokoloff, 1959; Douglas, 1975 ), yet intra-arterial histamine does not increase cerebral blood flow in monkeys (Eidelman et aI. , 1979) . (2) The two classes of histamine receptors, H I and H2, are both present in cerebral vessels (Edvinsson and Owman, 1975) , but could mediate different vascular re sponses (Owen, 1977; Brody, 1980) . For example, dilatation of pial arterioles by perivascular injection of histamine is mediated almost exclusively by Hzreceptors (Wahl and Kuschinsky, 1979) . (3) Fur thermore, histamine exhibits very poor penetration from blood across cerebral vessels to brain (Olden dorf, 1971) . These findings suggest that some of the confusion concerning histamine effects in the cere bral circulation may be related to such factors as species differences (Owen, 1977) , the type of his tamine receptor stimulated (Owen, 1977; Brody, 1980) , and the blood-brain barrier (MacKenzie et aI. , 1977) .
In these studies, we examined several aspects of histamine effects in the cerebral circulation of rats. First, we determined blood flow responses to his tamine when the blood-brain barrier was intact, and after it was disrupted, we established dose-response relationships for intracarotid infusion of histamine. Second, we determined blood flow responses to histamine in the presence of specific histamine re ceptor antagonists. Third, we examined regional blood flow responses to specific histamine receptor agonists. Fourth, we established whether the changes in blood flow that occurred were secondary to changes in brain glucose consumption.
METHODS

General
Experiments were performed with 73 male Sprague-Dawley rats weighing 275 -425 g. Anes thesia was induced with 3% halothane in oxy gen, the trachea was cannulated, and ventilation with 0. 4% halothane and NzO/Oz (70:30) was used to maintain anesthesia. Skeletal muscle paralysis was achieved with gallamine triethiodide (10 mg kg-l h-l, i. v. ), and heparin (750-1, 000 U kg-I, i. v. ) was used for anticoagulation.
Polyethylene catheters were placed in both femo ral arteries and veins for monitoring of blood pres sure, for withdrawal of arterial blood, and for drug and tracer administration. In all rats, arterial blood gases and pH were determined frequently. We made adjustments in respiratory tidal volume or gave small volumes of sodium bicarbonate (8. 4%) to correct Pcoz and pH. Body temperature was main tained at 37 ± OSC by external heating.
In 70 rats, a catheter was inserted retrogradely into the external carotid artery, and advanced to the origin of the internal carotid artery. Remaining arte rial branches near the carotid bifurcation, including the pterygopalatine artery, were ligated. In 19 of the rats, a catheter was also inserted into the axillary artery and advanced retrogradely through the sub clavian artery to the brachiocephalic trunk. Position of the catheter at the origin of the subclavian ar tery was verified by injection of Evans blue (�50 ILl) and immediate appearance of the dye in the com mon carotid artery. In 3 additional rats, the brain distribution of injectate from this catheter was quantified using the diffusible tracer, [ 14C]iodoan tipyrine. A 5 lLei bolus in 30 ILl saline was injected from the catheter, and the rat was decapitated five s later. Bilateral samples of brain regions were ob tained by dissection of the fresh brain and weighed.
In all studies requiring brain dissection, bilat eral samples were obtained from hypothalamus, thalamus, caudate nucleus, hippocampus, parietal cortex, and cerebrum. Midbrain, pons, medulla, and cerebellum, and, for one study, samples of cerebellar cortex were also taken. Specimens weighed 14 mg (hypothalamus) to 175 mg (cere brum). The tissues were analyzed for radioactivity by liquid scintillation counting, and radioactivity levels in the left and right brain regions were com pared.
Measurement of Cerebral Blood Flow 133Xenon
Sixteen rats were used to estimate cerebral blood flow from the clearance of 133Xe injected into the internal carotid artery (Hertz et aI. , 1977; Gross et aI. , 1981) . In these rats, the right parietal calvaria were exposed by reflection of overlying muscle and skin. A fine needle was inserted into the external carotid artery catheter and secured at the catheter tip near the origin of the internal carotid artery.
Our method for determination of cerebral blood flow with 133Xe has been described previously in detail (Gross et aI. , 1981) . Briefly, 10 ILCi (10 ILl) of 133Xe was rapidly injected from a microsyringe into the internal carotid artery, and the brain clearance of radioactivity was recorded for approximately 45 s. Blood flow was calculated from the initial slope index of a semilogarithmic plot of the clearance curve using the equation
where CBF is cerebral blood flow (in ml min-1 g-I), A the brain-blood partition coefficient for Xe in rat brain grey matter (0. 80; Nilsson and Siesjo, 1976) , and t 112 the half-time of 133Xe clearance in seconds. Flow measurements were possible every few min utes when background counts had decreased to less than 10% of peak activity. During control con ditions, the coefficient of variation of this method was 11%. Arterial blood pressure was measured at the time of each blood flow determination. We made calcu lations of cerebral vascular resistance by dividing mean arterial pressure by the blood flow estimate.
[14 C] I odoantipy rine
In 34 rats, measurements of regional cerebral blood flow were obtained by systemic administra tion of [ I 4C]iodoantipyrine and fresh dissection of brain regions. A method using this tracer for au toradiographic determination of cerebral blood flow in rats has been published recently (Sakurada et aI. , 1978) . The tracer (20 p,Ci in 1. 5 ml saline) was given intravenously over 30 s by ramp infusion, i. e. , the rate of infusion was increased progressively so that arterial tracer concentration would be highest at the end of the experiment. Throughout the experimen tal period, arterial blood dripped continuously from a femoral arterial catheter; 12-18 samples of blood were obtained separately on preweighed filter discs. The times of sampling were recorded and were used with the radioactivity of each blood sample to de rive an integral of arterial14C concentration over the course of the experiment. The rats were killed by decapitation immediately at the end of tracer infu sion. Brain regions were identified and dissected and were placed in tared scintillation vials for weighing. The brain and blood samples were analyzed for radioactivity by liquid scintillation counting. Calculations of blood flow for each of the brain regions were performed according to the equations of Sakurada et al. (1978) .
Measurement of Cerebral Glucose Utilization
Sixteen rats were used to determine whether ca rotid arterial infusion of histamine increased the rate of glucose metabolism in brain.
[14C]2-Deoxy glucose (10 p,Ci in 1 ml saline) was injected intra venously, and arterial blood was sampled repeat edly over the following 30 min. From the plasma of each blood sample, a 20 p,l aliquot was taken to determine radioactivity in the sample by liquid scintillation counting, and a 15 p,l aliquot was used to determine glucose concentration. At the end of the experiment, brain samples obtained by dis section were weighed and analyzed for radioactivity by liquid scintillation counting. Calculations for the derivation of glucose consumption were performed by computer according to the equations of Sokoloff et al. (1977) .
Blood-Brain Barrier Disruption
Because vascular endothelia in the cerebral cir culation may form a barrier to circulating histamine and its agonists, we disrupted blood-brain barrier mechanisms before intravascular infusion of these drugs. One ml of 2 M urea was injected over 30 s into the internal carotid artery. This technique has been shown previously in rats to increase cere brovascular permeability to norepinephrine (Ed vinsson et aI. , 1978) and to maintain an open barrier for at least 30 min (Hardebo, 1980) . In our studies, intracarotid drug infusions were begun 15 min after injection of urea.
The method we used for barrier disruption differs from that of Pappius et al. (1979) , who infused into the carotid artery 2. 5 ml of mannitol over 30 s in conscious, unheparinized rats. Ipsilateral to infu sion, these investigators found large variable de creases in local cerebral blood flow that may be related to platelet embolization. By contrast, there is no significant effect of carotid urea injection on cerebral blood flow in baboons (Pickard et aI. , 1977) or in anesthetized rats given heparin (see Table 4 ).
In additional studies of 4 rats, we determined cerebrovascular permeability to labeled sucrose after intracarotid urea injection in an attempt to quantify the extent of barrier disruption. [14C]SU crose (10 p,Ci in 0. 5 ml saline) was injected intrave nously 10 min after urea, and arterial blood was sampled for the following 10 min. Brain samples were obtained by dissection and were weighed and analyzed, with the plasma samples, by liquid scin tillation counting for radioactivity. Regional perme ability x surface area products were computed ac cording to the methods and vascular volume esti mates of Ohno et al. (1978) .
Drugs and Protocols
Drugs administered into the internal carotid ar tery were delivered by constant infusion at a rate of 451-1-1 min-I. Drug infusions were begun 5 min before measurements were obtained. In the xenon series, saline or histamine was administered into the brachiocephalic-common carotid trunk because the external carotid artery was used for injection of the xenon. In these rats, the infusate was expected to reach the brain because all remaining branches of the common carotid artery were ligated. Histamine dihydrochloride was given in doses of 2, 6, 20, and 60 p,g min-I kg-I after blood-brain barrier disruption by urea; only the 20 p,g dose was given before urea. Because the higher doses of histamine were as sociated with increases in cerebral blood flow (see Results), a histamine H I -or Hz-receptor antagonist, mepyramine maleate (May & Baker) or metiamide (Smith Kline & French), respectively, was admin istered (5 mg kg-I, i. v. ) after urea injection and 10 min before histamine infusion.
In experiments using iodoantipyrine to determine cerebral blood flow, histamine (20 p,g min-I kg-I) was infused from the external carotid artery cathe ter into the internal carotid artery of separate groups of rats before and after carotid urea injec tion. Because carotid infusion of histamine in this dose produced arterial hypotension, which could reduce cerebral vasodilator responses to histamine, 3 additional rats were used to examine histamine effects when blood pressure was maintained at normal levels. During carotid histamine infusion, a nylon snare was used to occlude the aorta at the level of the diaphragm, thereby maintaining arterial pressure in the cephalad part of the animal. The two axillary arteries were used to measure arterial pres sure and sample arterial blood, and the axillary or jugular vein was used for tracer infusion.
Other rats in the iodoantipyrine series received infusions of saline, the H I -receptor agonist 2, 2-pyridylethylamine (Smith Kline & French), or the H2-receptor agonist dimaprit (Smith Kline & French). Both agonists were given into the internal carotid artery in the dose of 200 p,g min-I kg-I after injection of urea.
To determine if histamine affected cerebral glu cose metabolism, both histamine (20 p,g min-I kg-I) and saline were infused continuously for 30 min in separate groups of rats after blood-brain barrier opening with urea. Continuous infusion of the agents was applied in an attempt to provide a "con stant" stimulus, which is one of the assumptions of the deoxyglucose technique (Sokoloff et aI. , 1977) . Two rats were used to demonstrate effects of intra carotid norepinephrine (6 p,g min-I kg-I) on cerebral glucose consumption after disruption of the blood brain barrier by urea.
Statistical Analyses
For the series involving the xenon method, for which dose-response relationships were deter mined, a one-way analysis of variance was used in a repeated-measures design; we used the Dunnett mUltiple-comparison test to determine differences between experimental and control groups.
Other experiments involved comparisons of re sponses in brain regions ipsilateral to drug infusion with those of contralateral (control) regions. For these comparisons, a paired nonparametric statistic was used (Steel and Torrie, 1960) . Results were ac cepted as significant at p < 0. 05. Other results are expressed as means ± standard error of the mean (SEM).
RESULTS
Two preliminary series were undertaken to eval uate the effectiveness of (1) brain distribution of substances infused into the common and internal carotid arteries from a catheter inserted into the subclavian artery, and (2) disruption of the blood brain barrier by carotid injection of hypertonic urea.
First, in the series using [ 14C]iodoantipyrine to evaluate cerebral distribution of 14C from subcla vian injection, we found that most of the 14C was present in the ipsilateral hemisphere. For 3 rats, results determined as dpm/mg and expressed in ratios of ipsilateral/contralateral were: caudate nu cleus, 10. 3; hippocampus, 4. 5; cerebrum, 5. 0; and frontoparietal cortex, 2. 7.
Second, in the group of 4 rats used to determine [ 14C]sucrose permeability after carotid urea injec tion, there was a significant increase in brain 14C ipsilateral to urea. The range of values for perme ability x surface area product in brain regions con tralateral to urea injection was 7. 5 to 10. 2 x 10-6 sec-I. Results were expressed as ipsilateral! contralateral ratios: caudate nucleus, 4. 2; hip pocampus, 4. 5; and parietotemporal cerebrum, 4. 6. Thus, the blood-brain barrier was four times more permeable to sucrose in brain regions ipsilateral to carotid injection of urea.
Responses to Histamine: Xenon
Intracarotid infusion of histamine before blood brain barrier disruption decreased arterial pressure, but did not change cerebral blood flow ( Table I) . Cerebral vascular resistance was significantly de- 67.8 ± 2.2 49.2 ± 1.8" 57.4 ± 8.6 51.1 ± 4.6' 1 39.4 ± 2.6" 36.9 ± 4.9" 65.4 ± 5.8
" CBF, cerebral blood flow estimate derived from initial slope of 1""Xe clearance.
" Significantly different from pre-infusion control (p < 0.05).
Histamine was infused into the internal carotid artery.
Values are means ± SEM.
creased (Table 1) . After urea, infusion of histamine in a low dose (2}-tg min-I kg-I) did not significantly increase cerebral blood flow, but higher doses (6, 20, and 60 }-tg min-1 kg-I) were effective ( Table 1) .
The increases in blood flow produced by these doses of histamine were 27 -50% above preinfusion control values (Fig. 1 ) and were associated with sig nificant decreases in vascular resistance (Table 1) . Additional flow measurements were obtained during infusion of histamine after intravenous ad ministration of the specific histamine receptor an- When the blood-brain barrier was intact (before urea) and at a low dose (2 p.g) after urea, histamine had no significant effect on blood flow. However, at higher doses (6-60 p.g) after urea, histamine infusion produced cerebral vasodilata tion.
tagonists mepyramine (H I ) or metiamide (H2)' Both antagonists reduced blood pressure and blood flow responses to histamine at the doses of 6, 20, and 60 }-tg min-I kg-I ; the H�-blocking agent metiamide was more effective (Table 2 ).
Responses to Histamine and Its Receptor
Agonists: Iodoantipyrine
Regional blood flow responses to histamine and its receptor agonists 2,2-pyridylethylamine (H I ) and dimaprit (H�) were determined using the diffusible tracer [ 14C]iodoantipyrine. Blood flow determina tions were made in three series: histamine infusion (intact blood-brain barrier) vs. control animals (unilateral carotid artery surgery alone, no infu sion); histamine infusion vs. saline infusion after ca rotid injection of urea; and 2, 2-pyridylethylamine vs. dimaprit after carotid injection of urea.
In control animals, there were no significant side-to-side differences in blood flow in any brain region (Table 3) . Infusion of histamine (20 }-tg min-1 kg-I) in animals not given a carotid injection of urea also did not produce any regional changes in cere bral blood flow (Table 3 ). Because histamine given by intracarotid infusion produced arterial hypoten sion (Tables 1 and 3 ), which, due to autoregulatory dilatation of brain vessels, might interfere with di latatory responses to histamine, we studied blood flow responses in 3 additional rats in which blood pressure was maintained by aortic constriction. Blood pressure before histamine infusion was 118 ± 13 mm Hg; during infusion it was 93 ± 13 mm Hg; 1.62 ± 0.14 6 f-Lg min-I kg-I 102 ± 6 2.20 ± 0.23" 100 ± 6 1.63 ± 0.06" 87 ± 10" 1.89 ± 0.18" 107 ± 6" 1.57 ± 0.15" Control 116 ± 6 1.40 ± 0.10 103 ± 8 1.45 ± 0.08 100 ± 7 1.53 ± 0.10 98 ± 5 1.52 ± 0.09 20 f-Lg min-I kg-I 83 ± 4" 2.14 ± 0.34" 100 ± 9" 1.77 ± 0.07"./' 88 ± 4" 2.24 ± 0.24" 93 ± 4 1.58 ± 0.11" Control 99 ± 5 1.59 ± 0.13 95 ± II 1.53 ± 0.09 104 ± 10 1.53 ± 0.15 113 ± 5 1.63 ± 0.12 60 f-Lg min-I kg-I 76 ± 7" 2.05 ± 0.23" 72 ± 18" 1.77 ± 0.09''-'' 76 ± 3" 2.45 ± 0.36" 107 ± 2" 1.59 ± 0.14"
" Significantly different from control value, p < 0.05. " Significantly different from response before blockade, p < 0.05.
Values are means ± SEM; 5 animals represented for each mean. Mepyramine and metiamide were given intravenously (5 mg kg-I) to separate groups of rats. Histamine was infused into the internal carotid artery after blooa-brain barrier disruption with urea.
Ahhreviations: MAP, mean arterial pressure in mm Hg; CBF. cerebral blood flow estimate from 13"Xe clearance, and expressed as ml min-I g -I.
and 30 s after the start of the experiment during histamine infusion and aortic occlusion, blood pres sure was 115 ± 17 mm Hg. Blood flow in the noninfused cerebrum was 1. 34 ± 0. 09 ml min-1 g-l, and in the infused cerebrum, 1. 26 ± 0. 09 ml min-1 g-l .
Infusion of saline after carotid injection of urea was associated with no change in regional blood flow (Table 4) ; there was a tendency for blood flow to be lower in several regions ipsilateral to infusion, but these differences were not statistically signifi cant (p > 0. 05; Table 4 ). Administration of his tamine after blood-brain barrier disruption, how ever, produced a reduction in arterial pressure and modest, but significant, increases in blood flow in hypothalamus (+9%), thalamus (+ 10%), parietal cortex (+31%), and cerebrum (+9%) ( Table 4) . There was a tendency for blood flow to be increased 
(5).
Values are means ± SEM. Saline and histamine (20 f.Lg min-I kg') were infused into the right internal carotid artery for 5 min. The infusions were begun 15 min after urea was injected into the carotid artery.
in caudate nucleus and hippocampus, but these changes were not significant (p > 0. 05; Table 4 ). In regions not perfused primarily by internal ca rotid artery blood, e. g. , brainstem and cerebellum. there were no significant side-to-side differences in blood flow during histamine infusion (Table 4) .
Carotid infusion of the histamine receptor agonist after urea injection produced significant flow increases in several brain regions (Table 5) . Stimulation of H I -receptors by 2, 2-pyridylethyl amine was associated with increased blood flow in hypothalamus (+29%), caudate nucleus (+20%), parietal cortex (+ 35%), and cerebrum (+ 10%) ( Table 5 ). Dimaprit evoked increases in blood flow (range. + 12 to 29%) in all territories examined in the distribution of the middle cerebral artery (Table 5 ). The magnitude of blood flow responses to the two receptor agonists was similar to that of histamine itself (Fig. 2) .
Effect of Histamine on Cerebral Glucose Utilization
Saline or histamine (20 (J.-g min-I kg-I ) was in fused into the carotid artery of rats following carotid injection of urea. Neither agent produced any re gional change in the rate of glucose consumption (Table 6 ). In order to establish whether the method could detect changes in glucose consumption, two additional animals were given an intracarotid infu sion of norepinephrine (6 (J.-g min-I kg-I) after blood-brain barrier disruption by urea. Norepineph rine produced an average increase in glucose uptake in caudate nucleus and parietal cortex by 31 and 43%, respectively; in midbrain, norepinephrine in fusion did not affect glucose utilization.
DISCUSSION
The principal findings in this study are as follows.
(1) When the blood-brain barrier was intact, intra arterial infusion of histamine did not increase cere bral blood flow; cerebral vascular resistance de creased to maintain blood flow constant during the arterial hypotension produced by histamine. (2) After disruption of the blood-brain barrier, infusion of histamine caused dose-dependent decreases in cerebral vascular resistance and increases in blood flow. Measurement of blood flow with a technique that permits regional assessment of perfusion indi cated that several brain structures were affected. (3) The increase in cerebral blood flow was mediated by both histamine HI-and H2-receptors. (4) The Regional CBF !l% !l%
.06 ± 0.14 1.18 ± 0.17" 10 ± 4 1.22 ± 0.16 1.38 ± 0.16" 12 ± 4 Diencephalon Hypothalamus 0.88 ± 0.06 1.13 ± 0.11" 29 ± 10 0.99 ± 0.10 1.14 ± 0.09" 15 ± 5 Thalamus 1.12 ±0 .16 1.29 ± 0.14 19 ± 13 1.18±0.14 1.36 ± 0.15" 15 ± 7 Hippocampus 0.90 ± 0.10 1.00 ± 0.12 11 ± 8 0.92 ± 0.13 1.13±0.13" 24 ± 3
Cerebral grey matter Caudate nucleus 1.12±0.10 1.35 ± 0.16" 20 ± 8 1.14 ± 0. increase in blood flow with histamine was a conse quence of the stimulation of vascular receptors mediating dilatation and was not a secondary re sponse to increased cerebral metabolism.
Effect of Histamine on Cerebral Vessels
There is considerable confusion in the literature regarding the effects of histamine on the cerebral circulation. A priori intra-arterial administration of histamine should not affect brain resistance vessels, because histamine itself has low permeability at the blood-brain barrier (Oldendorf, 1971) . Conversely, there have been many reports indicating that intra arterial infusion of histamine increases cerebral blood flow in several species (Table 7) . In these studies, measurements were obtained either by methods that determine flow in extracranial vessels supplying the brain and/or in species such as dogs and cats, in which there are anastamoses between major vessels serving the brain and vessels in extratation of the internal carotid artery, for example, cranial tissues (Chungcharoen et aI. , 1952; Jennett would not necessarily be associated with dilatation et aI., 1976). Each of these circumstances may lead of vessels distal to the circle of Willis. This separato errors in interpretation. Histamine-induced dilation of vascular responses has been clearly demon- Internal 20 I-'g kg-I
9-31% carotid min-I increasel/ H I and H, strated for the vasoconstrictor substance, 5-hydroxytryptamine : in baboons, intracarotid infusion of 5-hydroxytryp tamine caused marked constriction of the internal carotid artery but did not reduce cerebral blood flow unless the blood-brain barrier was disrupted. Cerebral vascular autoregulatory mechanisms would explain this phenomenon. Likewise, a similar series of events may apply to histamine: intracarotid infusion probably dilates the internal carotid artery (Spira et aI., 1978; Tindall and Greenfield, 1973) , but as shown in our studies (Fig. I) , and in those by Eidelman et al. (1979) , cerebral blood flow does not increase. Differences between species in distribution and density of cerebral vascular histamine receptors, in blood-brain barrier permeability, or in vascular anatomy could account for the discrepant results in different studies. Limitations of the dog for studies of cerebral circulatory responses to intra-arterial drug administration (Table 7) have been discussed recently (Heistad et aI. , 1980) .
The importance of the blood-brain barrier to cir culating amines is well-recognized (Oldendorf, 1971; MacKenzie et aI. , 1977) . In our studies, intra-arterial histamine had no effect on cerebral blood fl ow unless blood-brain barrier mechanisms were first disrupted by an intracarotid injection of hypertonic urea. We showed in preliminary experi ments that urea caused a fourfold increase in perme ability to sucrose (MW = 342 daltons). In a previous report (MacKenzie et aI. , 1977) , it was demon strated that intracarotid injection of urea in rats in creased the brain uptake of norepinephrine (MW = 168 daltons) by approximately fourfold. Thus, be cause histamine dihydrochloride has a similar mo lecular weight (184 daltons) to norepinephrine, bar rier permeability to histamine was probably in creased by about fourfold in our studies. Such an increase in permeability at the level of arterioles and metarterioles could explain the increase in blood flow that we observed if histamine were to affect, preferentially, inner layers of vascular smooth mus cle. It seems unlikely that passage of histamine from blood to the outside of cerebral vessels would ex plain our results because, along the outer surface of brain arterioles, the predominant receptors are of the H2-type (Wahl and Kuschinsky, 1979) ; in our studies, however, both H1-and H2-receptors par ticipated in vasodilatatory responses to histamine. Antagonists of both histamine receptor classes re duced dilatatory responses to histamine (Table 2) and both receptor agonists produced increases in blood flow (Fig. 2) . These results, and the studies of Wahl and Kuschinsky (1979) , indicate that his tamine H1-and H2-receptors may be localized dif ferentially within brain arterioles. This possibility has been discussed previously for other vascular beds (Brody, 1980) . Could the increases in cerebral blood flow with carotid infusion of histamine occur secondarily to increases in brain metabolism? The effects of other amines administered into the brain arterial supply have been explained by a coupling of blood flow to metabolic rate MacKenzie et aI. , 1977) . In our studies, however, brain utilization of glucose did not alter perceptibly when histamine was infused into the carotid artery following blood-brain barrier disruption. Because glucose consumption did increase when norepi nephrine was infused, it appears that the method using deoxyglucose was sensitive for recording changes in cerebral glucose utilization produced by intra-arterial stimuli. Rapid catabolism of histamine by its degradative enzymes, which are present in the brain (Taylor and Snyder, 1972) , could explain its lack of effect on neuronal metabolism. Increases in cerebral blood flow by another putative neuro transmitter, acetylcholine, are similarly mediated directly by vascular receptors, rather than indi rectly by increases in brain metabolism (Heistad et aI. , 1980) .
Does Histamine Participate in Endogenous
Mechanisms Affecting Cerebral Blood Flow?
There are several reasons to believe that his tamine has complex effects on cerebral vascular smooth muscle in vivo. Histamine is richly concen trated in the mast cells located along the adventitial borders of brain vessels (Ibrahim, 1974; Edvinsson et aI. , 1977) ; if histamine is released from these cells, potent vasoactive effects would likely occur. Another, non-mast cell, pool of histamine is found within cerebrovascular smooth muscle (EI-Ackad and Brody, 1974) . Although a specific function has not yet been associated with this histamine pool, it may modify the effects of cerebrovascular nerves. Histamine is found abundantly in peripheral au tonomic nerves (Brody, 1980 ), but it is not known whether nonsympathetic nerve endings found in close proximity to brain vessels (Ed vinsson et aI. , 1973) are histaminergic fibers. Alternatively, neu ronal activity mediated by histamine in its neu-rotransmitter role (Schwartz et aI. , 1980) could af fect brain vascular responses if there were central histaminergic nerves that had terminals innervating blood vessels; this kind of vascular innervation has been proposed for central noradrenergic neurons (Raichle et aI. , 1975) . However, there is no avail able morphological evidence to indicate that such histamine fibers exist.
Whatever the source of histamine, the type of histamine receptor activated may determine what vascular response occurs. For example, it has been demonstrated for brain arterioles that H2-receptors predominantly mediate dilatatory responses to his tamine administered by perivascular injection (Wahl and Kuschinsky, 1979) . By contrast, we found that both classes of receptors (H I and H2) mediated increases in cerebral blood flow (Fig. 2) . The magnitude of vascular response may also de pend on the brain region. Histamine content varies from structure to structure (Taylor and Snyder, 1972) , and so may the density and distribution of vascular receptors. This possibility is deduced from a comparison of blood flow responses to the recep tor agonists, 2, 2-pyridylethylamine (HI) and dima prit (H2)' in regions with relatively high histamine content, such as hypothalamus and hippocampus. In the hypothalamus, blood flow was increased more by 2, 2-pyridylethylamine, whereas dimaprit was more potent in the hippocampus (Table 5 ). These responses suggest that the distribution of vascular HI-and H2-receptors varies in different brain structures.
We conclude that a variety of factors may deter mine the effects of histamine on the cerebral circu lation. Vascular responses may depend on whether the source of histamine is from mast cells, from a non-mast cell pool, or from nerve terminals, and also on the type and location of histamine receptor that is stimulated.
